We're currently recruiting for a Professor of Chemistry working in:
- Medicinal chemistry
- Novel molecular therapeutic modalities
- Chemical biology
- AI-enabled therapeutic discovery
Interested? Apply now: https://t.co/uEfBT7oqMx
Do Amino-Oxetanes Resemble Amides? A Matched Molecular Pairs Property and Structural Comparison | Journal of Medicinal Chemistry https://t.co/XuNBDJjPps
Our latest work on the synthesis of heterocyclic fragments out now:
Regio‐ and Stereocontrolled‐Synthesis of a Heterocycle Fragment Collection Using Palladium Catalyzed C‐H Arylation
https://t.co/2KPpiH47S8
Hodan and Sarah's work in collaboration with @jamesabull and Phil Miller on transforming trifluoromethane (HFC-23) into fluoroalkenes is now out in @angew_chem here is the link: https://t.co/HkU29jdX4L
Do Amino-Oxetanes Resemble Amides?
Check out our Matched Molecular Pairs study in @ChemRxiv comparing properties and structure.
Congrats @hikaruishikura and coworkers, in collaboration with Pfizer.
https://t.co/ctoI5c1XeW
As asymmetric sulfur(VI) derivatives become more prevalent in the chemical sciences, especially in aza-derivatives, sulfoximines, sulfonimidamides, we have reviewed "The stereochemistry of substitution at S(VI)"
https://t.co/DrNcQxY8sS
Congrats to Freeman and Peerawat on our recent @ChemRxiv - Synthesis of Cyclic Sulfilimines and Sulfoximines via Copper Mediated C(sp2)–H Sulfanylation of Benzylamines with a Catalytic Transient Directing Group.
https://t.co/TlQ63eIjk5
Synthesis of Cyclic Sulfilimines and Sulfoximines via Copper-Mediated C(sp2)–H Sulfanylation of Benzylamines with a Catalytic Transient Directing Group by James A. Bull and co-workers (@jamesabull, @imperialcollege) #OpenAccess 🔓 https://t.co/cNATYp1Rry
New orthogonal SuFEx and SNAr reactivity of sulfonimidoyl fluorides and the automated synthesis of sulfonimidamides by @jamesabull and coworkers (@imperialcollege) #OpenAccess 🔓 https://t.co/kQsagcDNEY
Our work on the divergent synthesis of difluorocyclobutanes, now published in #JOC@JOC_OL.
Synthesis of gem-Difluorocyclobutanes: Organolanthanum Enabled Synthesis and Divergent Catalytic Functionalization of gem-Difluorocyclobutanols https://t.co/oVBip9GWPC
Interested in strained rings or fluorine for medicinal chemistry - check out Hikaru’s work on divergent synthesis of difluorocyclobutanes, on ChemRxiv:
https://t.co/FcOzvpl1Pp
SuFEx and SNAr on Sulfonimidoyl Fluorides - pleased this is now published in @ChemistryEur.
Catalytic SuFEx Reactivity of Sulfonimidoyl Fluorides with Functionalized Amines with Automation Applicable Conditions https://t.co/yE4vLudJLU
Happy to report our work on catalytic SuFEx with sulfonimidoyl fluorides - and switchable SNAr reacts also. Congrats to Nikki on her paper now on ChemRxiv
https://t.co/VT6G6htqQP
Electrochemical Copper Catalysis: A Triple Catalytic System for Transient C(sp2)–H Functionalization Through Mediated Electrolysis | @ChemRxiv
Congrats Freeman @TszKanMa1
https://t.co/VyXxa5Bpp3
Interested in strained rings or fluorine for medicinal chemistry - check out Hikaru’s work on divergent synthesis of difluorocyclobutanes, on ChemRxiv:
https://t.co/FcOzvpl1Pp
Happy to report our work on catalytic SuFEx with sulfonimidoyl fluorides - and switchable SNAr reacts also. Congrats to Nikki on her paper now on ChemRxiv
https://t.co/VT6G6htqQP
** New PhD position ** We are advertising a chemical biology studentship with Profs Vilar and Mann, in collaboration with GSK, with ICB CDT @icbcdt .
#automation, #Synthesis, #D2B.
Fully funded at UK fees level.
https://t.co/6lGXHFY8v2
Did you miss Ulrich Luecking’s talk about "Sulfoximines in Medicinal Chemistry: Unlocking Novel Opportunities in Drug Design"?
In this Flash Talk, Ulrich Luecking, VP and Head of Chemistry at FoRx Therapeutics, explores the untapped potential of sulfoximines in modern drug discovery. He highlights several exciting development candidates on novel and established targets such as AZ's ATR inhibitor ceralasertib, Artios' ATR inhibitor ART0380, Tango's CoREST complex inhibitor TNG-260, and many more. Ulrich also showcases the use of sulfoximines beyond traditional small molecules and exemplifies innovative synthetic strategies for accessing them.
A standout moment in the talk was the first time disclosure of FORX-1589, a covalent WRN inhibitor featuring a novel vinyl sulfoximine warhead. The patent application containing this compound was just published last week.
The Flash Talk concluded with a lively Q&A where Ulrich answered many insightful audience questions. Watch the full Flash Talk on our YouTube channel now and don't forget to share it with a colleague who'd appreciate knowing more about the use of sulfoximines as an innovative functional group!
Watch Now: https://t.co/Z6Drtz89PQ
Last update of our "useful link" website: we added a few computational tools and compound databases useful for organic chemists! (Just a start, happy to add more in the future)
https://t.co/QKs07QQCAv
🌟 Unlock Your Potential in Advanced Molecular Synthesis!
Join the MRes in Advanced Molecular Synthesis at @imperialcollege and gain skills and knowledge to excel in the dynamic field of molecular synthesis.
🔗 Learn More and Apply Today! https://t.co/wMJTJDdmhf
#Chemistry